Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study
Titel:
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study
Auteur:
Tolosa, Pablo Pascual, Tomás Martínez-Saez, Olga Hernando, Cristina Servitja, Sonia Fernández Abad, María Brasó-Maristany, Fara Sanfeliu, Ester Benitez Fuentes, Javier David Lema, Laura Ruano, Yolanda García-Fructuoso, Isabel Parrilla, Lucía Rodríguez, Adela Roncero, Ana María Cobos, María Ángeles Sánchez-Bayona, Rodrigo Alva, Manuel Madariaga, Ainhoa Villacampa, Guillermo Canes, Jordi Salvador, Fernando Sánchez-Belmonte, Agustín Malumbres, Marcos Prat, Aleix Ciruelos, Eva